These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 24664471)

  • 1. Outfoxed by RBFOX1-a caution about ascertainment bias.
    Kamien B; Lionel AC; Bain N; Scherer SW; Hunter M
    Am J Med Genet A; 2014 Jun; 164A(6):1411-8. PubMed ID: 24664471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orchestration of neurodevelopmental programs by RBFOX1: implications for autism spectrum disorder.
    Bill BR; Lowe JK; Dybuncio CT; Fogel BL
    Int Rev Neurobiol; 2013; 113():251-67. PubMed ID: 24290388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of RBFOX1 gene expression in lymphoblastoid cell lines of Italian discordant autism spectrum disorders sib-pairs.
    Prandini P; Zusi C; Malerba G; Itan ; Pignatti PF; Trabetti E
    Mol Cell Probes; 2014; 28(5-6):242-5. PubMed ID: 24938762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinically relevant single gene or intragenic deletions encompassing critical neurodevelopmental genes in patients with developmental delay, mental retardation, and/or autism spectrum disorders.
    Mikhail FM; Lose EJ; Robin NH; Descartes MD; Rutledge KD; Rutledge SL; Korf BR; Carroll AJ
    Am J Med Genet A; 2011 Oct; 155A(10):2386-96. PubMed ID: 22031302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extending the phenotypic spectrum of RBFOX1 deletions: Sporadic focal epilepsy.
    Lal D; Pernhorst K; Klein KM; Reif P; Tozzi R; Toliat MR; Winterer G; Neubauer B; Nürnberg P; Rosenow F; Becker F; Lerche H; Kunz WS; Kurki MI; Hoffmann P; Becker AJ; Perucca E; Zara F; Sander T; Weber YG
    Epilepsia; 2015 Sep; 56(9):e129-33. PubMed ID: 26174448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rare inherited A2BP1 deletion in a proband with autism and developmental hemiparesis.
    Davis LK; Maltman N; Mosconi MW; Macmillan C; Schmitt L; Moore K; Francis SM; Jacob S; Sweeney JA; Cook EH
    Am J Med Genet A; 2012 Jul; 158A(7):1654-61. PubMed ID: 22678932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurodevelopmental disorders among individuals with duplication of 4p13 to 4p12 containing a GABAA receptor subunit gene cluster.
    Polan MB; Pastore MT; Steingass K; Hashimoto S; Thrush DL; Pyatt R; Reshmi S; Gastier-Foster JM; Astbury C; McBride KL
    Eur J Hum Genet; 2014 Jan; 22(1):105-9. PubMed ID: 23695283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytogenetic and molecular characterization of A2BP1/FOX1 as a candidate gene for autism.
    Martin CL; Duvall JA; Ilkin Y; Simon JS; Arreaza MG; Wilkes K; Alvarez-Retuerto A; Whichello A; Powell CM; Rao K; Cook E; Geschwind DH
    Am J Med Genet B Neuropsychiatr Genet; 2007 Oct; 144B(7):869-76. PubMed ID: 17503474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refinement and discovery of new hotspots of copy-number variation associated with autism spectrum disorder.
    Girirajan S; Dennis MY; Baker C; Malig M; Coe BP; Campbell CD; Mark K; Vu TH; Alkan C; Cheng Z; Biesecker LG; Bernier R; Eichler EE
    Am J Hum Genet; 2013 Feb; 92(2):221-37. PubMed ID: 23375656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intragenic rearrangements in NRXN1 in three families with autism spectrum disorder, developmental delay, and speech delay.
    Wiśniowiecka-Kowalnik B; Nesteruk M; Peters SU; Xia Z; Cooper ML; Savage S; Amato RS; Bader P; Browning MF; Haun CL; Duda AW; Cheung SW; Stankiewicz P
    Am J Med Genet B Neuropsychiatr Genet; 2010 Jul; 153B(5):983-93. PubMed ID: 20162629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural, genetic, and functional signatures of disordered neuro-immunological development in autism spectrum disorder.
    Saxena V; Ramdas S; Ochoa CR; Wallace D; Bhide P; Kohane I
    PLoS One; 2012; 7(12):e48835. PubMed ID: 23239965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Copy number and sequence variants implicate APBA2 as an autism candidate gene.
    Babatz TD; Kumar RA; Sudi J; Dobyns WB; Christian SL
    Autism Res; 2009 Dec; 2(6):359-64. PubMed ID: 20029827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel X-linked disorder with developmental delay and autistic features.
    Kaya N; Colak D; Albakheet A; Al-Owain M; Abu-Dheim N; Al-Younes B; Al-Zahrani J; Mukaddes NM; Dervent A; Al-Dosari N; Al-Odaib A; Kayaalp IV; Al-Sayed M; Al-Hassnan Z; Nester MJ; Al-Dosari M; Al-Dhalaan H; Chedrawi A; Gunoz H; Karakas B; Sakati N; Alkuraya FS; Gascon GG; Ozand PT
    Ann Neurol; 2012 Apr; 71(4):498-508. PubMed ID: 22213401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of copy-number variation in AUTS2 gene by targeted exonic array CGH in patients with developmental delay and autistic spectrum disorders.
    Nagamani SC; Erez A; Ben-Zeev B; Frydman M; Winter S; Zeller R; El-Khechen D; Escobar L; Stankiewicz P; Patel A; Cheung SW
    Eur J Hum Genet; 2013 Mar; 21(3):343-6. PubMed ID: 22872102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rare exonic deletions of the RBFOX1 gene increase risk of idiopathic generalized epilepsy.
    Lal D; Trucks H; Møller RS; Hjalgrim H; Koeleman BP; de Kovel CG; Visscher F; Weber YG; Lerche H; Becker F; Schankin CJ; Neubauer BA; Surges R; Kunz WS; Zimprich F; Franke A; Illig T; Ried JS; Leu C; Nürnberg P; Sander T; ;
    Epilepsia; 2013 Feb; 54(2):265-71. PubMed ID: 23350840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Special Report: Chromosomal Microarray for the Genetic Evaluation of Patients With Global Developmental Delay, Intellectual Disability, and Autism Spectrum Disorder.
    Blue Cross Blue Shield Asssociation
    Technol Eval Cent Assess Program Exec Summ; 2015 Aug; 30(2):1-4. PubMed ID: 26376503
    [No Abstract]   [Full Text] [Related]  

  • 17. Copy Number Variations in CTNNA3 and RBFOX1 Associate with Pediatric Food Allergy.
    Li J; Fung I; Glessner JT; Pandey R; Wei Z; Bakay M; Mentch FD; Pellegrino R; Wang T; Kim C; Hou C; Wang F; Chiavacci RM; Thomas KA; Spergel JM; Hakonarson H; Sleiman PM
    J Immunol; 2015 Aug; 195(4):1599-607. PubMed ID: 26188062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic spectrum associated with de novo and inherited deletions and duplications at 16p11.2 in individuals ascertained for diagnosis of autism spectrum disorder.
    Fernandez BA; Roberts W; Chung B; Weksberg R; Meyn S; Szatmari P; Joseph-George AM; Mackay S; Whitten K; Noble B; Vardy C; Crosbie V; Luscombe S; Tucker E; Turner L; Marshall CR; Scherer SW
    J Med Genet; 2010 Mar; 47(3):195-203. PubMed ID: 19755429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Disease susceptibility genes and genome structural abnormalities associated with developmental disabilities].
    Yamamoto T
    No To Hattatsu; 2014 Mar; 46(2):131-5. PubMed ID: 24738191
    [No Abstract]   [Full Text] [Related]  

  • 20. PARK2 copy number aberrations in two children presenting with autism spectrum disorder: further support of an association and possible evidence for a new microdeletion/microduplication syndrome.
    Scheuerle A; Wilson K
    Am J Med Genet B Neuropsychiatr Genet; 2011 Jun; 156B(4):413-20. PubMed ID: 21360662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.